Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease - A prospective study in healthy volunteers

Digestive Diseases and Sciences

Volumn 39, Issue 5, 1994, Pages 1085-1089

  Thillainayagam, A V ^a   Tabaquchali, S ^a   Warrington, S J ^a   Farthing, M J G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

gastroduodenal mucosal injury; Helicobacter pylori; nonsteroidal antiinflammatory drugs

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PLACEBO;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOSCOPY; FEMALE; GASTRODUODENAL ULCER; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL SYMPTOM; HELICOBACTER PYLORI; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-CYCLODEXTRINS; CYCLODEXTRINS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INDOMETHACIN; MALE; PIROXICAM; PROSPECTIVE STUDIES;

EID: 0028340325     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/BF02087562     Document Type: Article

References (31)

1. Helicobacter pylori and peptic ulcer disease
2. Campylobacter pylori and peptic ulcer disease
3. Prevention of gastroduodenal injury induced by chronic non-steroidal anti-inflammatory drug therapy
4. Upadhyay R, Howatson A, McKinlay A, Sturrock R, Russell RI: Gastritis associated with campylobacter-like organisms in patients with rheumatoid arthritis taking nonsteroidal anti-inflammatory drugs. Gut 27:A1237, 1986
5. Campylobacter pylori associated gastritis in patients with rheumatoid arthritis taking nonsteroidal anti-inflammatory drugs
6. Assessment of Campylobacter-like organisms in the post-operative stomach, iatrogenic gastritis and chronic gastroduodenal disease: preliminary observations
7. Gastroduodenal complications of chronic NSAID therapy
8. Non-steroidal anti-inflammatory drug-induced dyspepsia—Is Campylobacter pyloridis implicated?
9. Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo or indomethacin
10. The presence of Camplyobacter pylori in nonsteroidal anti-inflammatory drug associated gastritis
11. Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to non-steroidal anti-inflammatory drug (NSAID) treatment in rheumatoid arthritis
12. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers
13. The interaction between Helicobacter pylori culture infiltrate and indomethacin: Effects on the integrity of human gastric antral mucosa and its prostaglandin E2 production in vitro
14. Long-term non-steroidal anti-inflammatory drugs use and Helicobacter pylori infection
15. A prospective endoscopic study of the effect of Oridis and Oruvail on the upper gastrointestinal tract, in patients with osteoarthritis
16. The effects of ibuprofen, indomethacin, aspirin, naproxen and placebo on the gastric mucosa of normal volunteers: A gastroscopic and photographic study
17. Endoscopic evaluation of the effects of aspirin, buffered aspirin and enteric-coated aspirin on gastric and duodenal mucosa
18. Utilization of nonsteroidal antiinflammatory drugs
19. Peptic ulcer, non-steroid anti-inflammatory drugs and the rheumatic diseases
20. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer
21. A multicenter study of hospitalization in rheumatoid arthritis. Frequency, medical-surgical admissions, and charges
22. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons
23. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States
24. Campylobacter pylori antibodies in humans
25. Effect of age on the frequency of active Campylobacter pylori infection diagnosed by the [13C]urea breath test in normal subjects and patients with peptic ulcer disease
26. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis
27. A comparison of the effects of HP 549 (Isoxepac), indomethacin and acetylsalicylic acid (aspirin) on gastric mucosa in man
28. A double blind randomized placebo controlled gastroscopic study to compare the effects of indomethacin capsules and indomethacin suppositories on the gastric mucosa of human volunteers
29. Endoscopic evaluation of the effect of indomethacin capsules and suppositories on the gastric mucosa in rheumatic patients
30. SEM study 1: Gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs (aspirin, piroxicam) in man